To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656

Clinical trial NCT01083212 · COMPLETED

Trial details

NCT number: NCT01083212
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-03-01
Primary completion: 2010-06-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.